Development of Multidrug Resistant Tuberculosis in Bangladesh: A Case-Control Study on Risk Factors

被引:50
|
作者
Rifat, Mahfuza [1 ,2 ]
Milton, Abul Hasnat [1 ]
Hall, John [1 ]
Oldmeadow, Christopher [1 ]
Islam, Md. Akramul [2 ]
Husain, Ashaque [3 ]
Akhanda, Md. Wahiduzzaman [4 ]
Siddiquea, Bodrun Naher [2 ]
机构
[1] Univ Newcastle, Newcastle, NSW 2300, Australia
[2] BRAC, Dhaka, Bangladesh
[3] Directorate Gen Hlth Serv, Natl TB Control Programme, Dhaka, Bangladesh
[4] Natl Inst Dis Chest & Hosp, Dhaka, Bangladesh
来源
PLOS ONE | 2014年 / 9卷 / 08期
关键词
DRUG-RESISTANCE; PREVALENCE; POPULATION;
D O I
10.1371/journal.pone.0105214
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Objective: To determine the risk factors for developing multidrug resistant tuberculosis in Bangladesh. Methods: This case-control study was set in central, district and sub-district level hospitals of rural and urban Bangladesh. Included were 250 multidrug resistant tuberculosis (MDR-TB) patients as cases and 750 drug susceptible tuberculosis patients as controls. We recruited cases from all three government hospitals treating MDR-TB in Bangladesh during the study period. Controls were selected randomly from those local treatment units that had referred the cases. Information was collected through face-to-face interviews and record reviews. Unadjusted and multivariable logistic regression were used to analyse the data. Results: Previous treatment history was shown to be the major contributing factor to MDR-TB in univariate analysis. After adjusting for other factors in multivariable analysis, age group "18-25'' (OR 1.77, CI 1.07-2.93) and "26-45'' (OR 1.72, CI 1.12-2.66), some level of education (OR 1.94, CI 1.32-2.85), service and business as occupation (OR 2.88, CI 1.29-6.44; OR 3.71, CI 1.59-8.66, respectively), smoking history (OR 1.58, CI 0.99-2.5), and type 2 diabetes (OR 2.56 CI 1.51-4.34) were associated with MDR-TB. Previous treatment was not included in the multivariable analysis as it was correlated with multiple predictors. Conclusion: Previous tuberculosis treatment was found to be the major risk factor for MDR-TB. This study also identified age 18 to 45 years, some education up to secondary level, service and business as occupation, past smoking status, and type 2 diabetes as comorbid illness as risk factors. National Tuberculosis programme should address these risk factors in MDR-TB control strategy. The integration of MDR-TB control activities with diabetes and tobacco control programmes is needed in Bangladesh.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] Factors related to previous tuberculosis treatment of patients with multidrug-resistant tuberculosis in Bangladesh
    Rifat, Mahfuza
    Hall, John
    Oldmeadow, Christopher
    Husain, Ashaque
    Hinderaker, Sven Gudmund
    Milton, Abul Hasnat
    BMJ OPEN, 2015, 5 (09):
  • [42] Factors Contributing to the High Prevalence of Multidrug-Resistant Tuberculosis Among Previously Treated Patients: A Case-Control Study from China
    Wang, Kai
    Chen, Songhua
    Wang, Xiaomeng
    Zhong, Jieming
    Wang, Xinting
    Huai, Pengcheng
    Wu, Limin
    Wang, Lixia
    Jiang, Shiwen
    Li, Jun
    Peng, Ying
    Yao, Hongyan
    Ma, Wei
    MICROBIAL DRUG RESISTANCE, 2014, 20 (04) : 294 - 300
  • [43] Bovine tuberculosis in Northern Ireland: a case-control study of herd risk factors
    Denny, GO
    Wilesmith, JW
    VETERINARY RECORD, 1999, 144 (12) : 305 - 310
  • [44] Risk factors for bovine anthrax in Bangladesh, 2010-2014: a case-control study
    Rume, F. I.
    Karim, M. R.
    Ahsan, C. R.
    Yasmin, M.
    Biswas, P. K.
    EPIDEMIOLOGY AND INFECTION, 2020, 148
  • [45] Risk factors for extensive drug resistance in multidrug-resistant tuberculosis cases: a case-case study
    Guglielmetti, L.
    Veziris, N.
    Aubry, A.
    Brossier, F.
    Bernard, C.
    Sougakoff, W.
    Jarlier, V.
    Robert, J.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2018, 22 (01) : 54 - +
  • [46] Proportions and Risk Factors of Developing Multidrug Resistance Among Patients with Tuberculosis in China: A Population-Based Case-Control Study
    Huai, Pengcheng
    Huang, Xinghe
    Cheng, Jun
    Zhang, Canyou
    Wang, Kai
    Wang, Xinting
    Yang, Liping
    Deng, Zhengyi
    Ma, Wei
    MICROBIAL DRUG RESISTANCE, 2016, 22 (08) : 717 - 726
  • [47] Multidrug resistant tuberculosis in France 1992-4: two case-control studies
    Schwoebel, V
    Decludt, B
    de Benoist, AC
    Haeghebaert, S
    Torrea, G
    Vincent, V
    Grosset, J
    BRITISH MEDICAL JOURNAL, 1998, 317 (7159): : 630 - 631
  • [48] Multidrug-resistant tuberculosis: Epidemiology and risk factors
    Fourati, S. Smaoui
    Mzid, H.
    Marouane, C.
    Kammoun, S.
    Messadi-Akrout, F.
    REVUE DE PNEUMOLOGIE CLINIQUE, 2015, 71 (04) : 233 - 241
  • [49] Determinants of multidrug-resistant tuberculosis among adults undergoing treatment for tuberculosis in Tigray Region, Ethiopia: a case-control study
    Zereabruk, Kidane
    Kahsay, Tensay
    Teklemichael, Hiyab
    Aberhe, Woldu
    Hailay, Abrha
    Mebrahtom, Guesh
    Bezabh, Gebrewahd
    BMJ OPEN RESPIRATORY RESEARCH, 2024, 11 (01)
  • [50] Risk factors for multidrug-resistant Pseudomonas aeruginosa acquisition. Impact of antibiotic use in a double case-control study
    Montero, M.
    Sala, M.
    Riu, M.
    Belvis, F.
    Salvado, M.
    Grau, S.
    Horcajada, J. P.
    Alvarez-Lerma, F.
    Terradas, R.
    Orozco-Levi, M.
    Castells, X.
    Knobel, H.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2010, 29 (03) : 335 - 339